Pharmacy & Prescribing
Polypharmacy, drug interactions, and prescribing safety
MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its June 2026 safety roundup, consolidating critical alerts for…
Editor's Top Picks
Creatine for Brain Health: What the Evidence Actually Shows
Creatine's muscle-building effects are supported by robust evidence, but cognitive claims rest on a weaker, population-specific foundation. A comprehensive literature…
Submit Your Paper →
More form Pharmacy & Prescribing
Melatonin’s safety paradox: effective sleep aid undermined by unregulated product quality
Melatonin is clinically effective for sleep disorders, but unregulated supplement manufacturing in the US creates…
L-Theanine Improves Task Accuracy Without Expected Brain Wave Changes, Research Shows
L-theanine marketing claims about alpha brain wave enhancement lack experimental support in controlled testing without…
Half of Commercial Fish Oil Supplements Exceed Oxidation Safety Limits—But Human Risk Remains Unclear
Approximately 40–50% of commercial fish oil supplements exceed voluntary oxidation safety limits, yet a 2012…
Why vitamin D prescriptions favour weekly boluses over daily doses — and what the evidence says
Vitamin D prescriptions typically specify 50,000 IU weekly, a pattern driven by patient adherence rather…
Eli Lilly cuts 340B drug discounts to hospitals failing to report claims data
Eli Lilly has begun eliminating federally mandated drug price breaks to hospitals that failed to…